Clinical trial · Observational
Cannabis Use in Cancer Patients
Effects of Cannabis Use in Cancer Patients: A Feasibility Study
NCT03617692CI-TRIAL-00077873completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor, Adult | Adult Solid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Oral Cannabis
- description
- This is an observational study of individuals who have already decided to try cannabis for their cancer treatment-related symptoms. A research assistant will provide information on the range of edible cannabis products and basic information about their various cannabinoid profiles, approximate prices, and nearby locations where participants may choose to purchase their product. Participants will then initiate use of an orally administered product they have selected and obtained. Participants will take the product as they see fit, without any frequency or dosing instructions from study staff, for two weeks.
Primary outcomes (1)
- measure
- Likelihood of Accruing Participants: Feasibility of Enrollment
- timeFrame
- Approximately 48 months
- description
- Enroll a minimum of 30 patients and demonstrate reasonable compliance with study procedures within 54 months of active recruiting.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Provision to sign and date the consent form. 2. Stated willingness to comply with all study procedures and be available for the duration of the study. 3. Be a female or male aged at least 21 years. 4. Have a diagnosis of any solid tumor type who has or is undergoing either curative or palliative treatment 5. Have intent or interest to use cannabis to treat their symptoms. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Report of other non-prescription drug use, such as cocaine, heroin, methamphetamine in the past 60 days 2. Actively seeking or in treatment for any substance use disorder 3. Acute illness other than cancer that could affect cognition or compliance per the decision of the study M.D. 4. Premenopausal females who are pregnant or trying to become pregnant. Note that pregnancy testing will not be required. 5. A Telephone Interview for Cognitive Status (TICS) score indicating moderate or severe cognitive impairment at screening
References
Publications (0)
Data not yet available
No reference posted for this study.